179 related articles for article (PubMed ID: 36098580)
1. Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.
Klobucar K; Jardine E; Farha MA; MacKinnon MR; Fragis M; Nkonge B; Bhando T; Borrillo L; Tsai CN; Johnson JW; Coombes BK; Magolan J; Brown ED
ACS Infect Dis; 2022 Oct; 8(10):2187-2197. PubMed ID: 36098580
[TBL] [Abstract][Full Text] [Related]
2. The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria.
Tang M; Zhao D; Liu S; Zhang X; Yao Z; Chen H; Zhou C; Zhou T; Xu C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762115
[TBL] [Abstract][Full Text] [Related]
3. An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria.
Cox G; Koteva K; Wright GD
J Antimicrob Chemother; 2014 Jul; 69(7):1844-55. PubMed ID: 24627312
[TBL] [Abstract][Full Text] [Related]
4. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
[TBL] [Abstract][Full Text] [Related]
5. A forward chemical screen identifies antibiotic adjuvants in Escherichia coli.
Taylor PL; Rossi L; De Pascale G; Wright GD
ACS Chem Biol; 2012 Sep; 7(9):1547-55. PubMed ID: 22698393
[TBL] [Abstract][Full Text] [Related]
6. Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria.
Uppu DSSM; Konai MM; Sarkar P; Samaddar S; Fensterseifer ICM; Farias-Junior C; Krishnamoorthy P; Shome BR; Franco OL; Haldar J
PLoS One; 2017; 12(8):e0183263. PubMed ID: 28837596
[TBL] [Abstract][Full Text] [Related]
7. New potentiators of ineffective antibiotics: Targeting the Gram-negative outer membrane to overcome intrinsic resistance.
Klobucar K; Brown ED
Curr Opin Chem Biol; 2022 Feb; 66():102099. PubMed ID: 34808425
[TBL] [Abstract][Full Text] [Related]
8. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
[TBL] [Abstract][Full Text] [Related]
9. Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.
Meng F; Liu Y; Nie T; Tang C; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
Appl Environ Microbiol; 2022 May; 88(10):e0037122. PubMed ID: 35499329
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-Derived Peptides Potentiate the Activity of Gram-Positive-Specific Antibiotics against Gram-Negative Bacteria.
Wesseling CMJ; Wood TM; Bertheussen K; Lok S; Martin NI
Molecules; 2021 Mar; 26(7):. PubMed ID: 33808488
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Ueda Y; Sunagawa M
Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
13. Synergism between Rifampicin and Cationic Polyurethanes Overcomes Intrinsic Resistance of
Tantisuwanno C; Dang F; Bender K; Spencer JD; Jennings ME; Barton HA; Joy A
Biomacromolecules; 2021 Jul; 22(7):2910-2920. PubMed ID: 34085824
[TBL] [Abstract][Full Text] [Related]
14. Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies.
Dhanda G; Sarkar P; Samaddar S; Haldar J
J Med Chem; 2019 Apr; 62(7):3184-3205. PubMed ID: 30404451
[TBL] [Abstract][Full Text] [Related]
15. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
16. A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli.
Baker KR; Jana B; Franzyk H; Guardabassi L
Antimicrob Agents Chemother; 2016 Oct; 60(10):5995-6002. PubMed ID: 27458225
[TBL] [Abstract][Full Text] [Related]
17. Synergy of outer membrane disruptor SLAP-S25 with hydrophobic antibiotics against Gram-negative pathogens.
Yang Z; Song M; Li X; Zhang Q; Shen J; Zhu K
J Antimicrob Chemother; 2022 Dec; 78(1):263-271. PubMed ID: 36385317
[TBL] [Abstract][Full Text] [Related]
18. Chemical Screen for Vancomycin Antagonism Uncovers Probes of the Gram-Negative Outer Membrane.
Klobucar K; Côté JP; French S; Borrillo L; Guo ABY; Serrano-Wu MH; Lee KK; Hubbard B; Johnson JW; Gaulin JL; Magolan J; Hung DT; Brown ED
ACS Chem Biol; 2021 May; 16(5):929-942. PubMed ID: 33974796
[TBL] [Abstract][Full Text] [Related]
19. Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria.
Ramirez D; Berry L; Domalaon R; Brizuela M; Schweizer F
ACS Infect Dis; 2020 Jun; 6(6):1413-1426. PubMed ID: 32357292
[TBL] [Abstract][Full Text] [Related]
20. Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold.
Green AT; Moniruzzaman M; Cooper CJ; Walker JK; Smith JC; Parks JM; Zgurskaya HI
Biochim Biophys Acta Gen Subj; 2020 Jun; 1864(6):129546. PubMed ID: 32032658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
